152
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia

, , , , , , , , , , , , , , , & show all
Pages 1874-1877 | Received 06 Jul 2014, Accepted 28 Sep 2014, Published online: 14 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shin-ichiro Fujiwara, Kazuo Muroi, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki & Keiya Ozawa. (2017) CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia. Hematology 22:6, pages 347-353.
Read now
Shuntaro Ikegawa, Noriko Doki, Shuhei Kurosawa, Tsukasa Yamaguchi, Masahiro Sakaguchi, Kaito Harada, Keita Yamamoto, Yutaro Hino, Naoki Shingai, Yasushi Senoo, Keiichiro Hattori, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kyoko Haraguchi, Yoshiki Okuyama & Kazuteru Ohashi. (2016) CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission. Leukemia & Lymphoma 57:6, pages 1375-1381.
Read now

Articles from other publishers (1)

Kazunori Nakase, Kenkichi Kita, Taiichi Kyo, Takanori Ueda, Isao Tanaka & Naoyuki Katayama. (2015) Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor ?-Chain (CD25) Expression Predicts a Poor Prognosis. PLOS ONE 10:9, pages e0128998.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.